(Q38356417)

English

Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Laurence Fourrier

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Peter Brooks

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jean-Marc Malinge

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

24 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

278

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

21267-21275

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mechanisms of resistance to cisplatin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Interstrand cross-links of cisplatin induce striking distortions in DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Transplacental mutagenicity of cisplatin: H-ras codon 12 and 13 mutations in skin tumors of SENCAR mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mechanisms of accurate translesion synthesis by human DNA polymerase eta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mechanisms of tolerance to DNA damaging therapeutic drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Isolation of an hMSH2-p160 Heterodimer That Restores DNA Mismatch Repair to Tumor Cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The Escherichia coli MutL protein stimulates binding of Vsr and MutS to heteroduplex DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

ATP hydrolysis-dependent formation of a dynamic ternary nucleoprotein complex with MutS and MutL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Escherichia coli MutY protein has a guanine-DNA glycosylase that acts on 7,8-dihydro-8-oxoguanine:guanine mispair to prevent spontaneous G:C-->C:G transversions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Distinct MutS DNA-binding modes that are differentially modulated by ATP binding and hydrolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

MutS mediates heteroduplex loop formation by a translocation mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Potential double-flipping mechanism by E. coli MutY.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Mismatch-containing oligonucleotide duplexes bound by the E. coli mutS-encoded protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Recognition of cisplatin adducts by cellular proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Xeroderma pigmentosum complementation group A protein (XPA) modulates RPA-DNA interactions via enhanced complex stability and inhibition of strand separation activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Biochemical characterization of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 complex and mispaired bases in DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Activation of human MutS homologs by 8-oxo-guanine DNA damage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

MutS interaction with mismatch and alkylated base containing DNA molecules detected by optical biosensor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The effect of O6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Structural and Kinetic Studies of a Cisplatin-modified DNA Icosamer Binding to HMG1 Domain B

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase β

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Recognition of DNA alterations by the mismatch repair system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

T4 endonuclease VII. Importance of a histidine-aspartate cluster within the zinc-binding domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Multiple pathways of recombination define cellular responses to cisplatin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301390200

21 January 2018

Identifiers

10.1074/JBC.M301390200

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

release_xubeswukuvffrdasapqmmejhem

1 reference

https://api.fatcat.wiki/v0/release/xubeswukuvffrdasapqmmejhem

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38356417&oldid=1839399744"